口服固體製劑市場規模、佔有率及成長分析（按劑型、藥物釋放機制、通路、應用、製造路線、形式及地區）－產業預測，2025-2032

2023 年口服固體製劑市場規模價值 6,454.2 億美元，預計將從 2024 年的 6,867.3 億美元成長到 2032 年的 11,280.2 億美元，預測期內（2025-2032 年）的複合年成長率為 6.4%。

由於口服藥物需求的不斷增加和配方技術的進步，全球口服固體製劑市場預計將經歷強勁成長。需要長期藥物治療的老齡化人口進一步推動了市場向創新藥物傳遞方法的發展，以提高患者的依從性和治療效果。日益嚴格的政府監管迫使製藥公司注重品質和安全，增加了對研發的投資。此外，製藥公司和受託製造廠商之間的策略聯盟正在擴大產品系列併加強市場動態。因此，口服固體製劑市場正在不斷發展，以滿足醫療保健產業的動態需求。

目錄

介紹

• 調查目的
• 定義
• 市場覆蓋

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概覽展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場動態
  • 驅動程式
  • 機會
  • 限制因素
  • 任務
• 波特的分析

關鍵市場考察

• 技術分析
• 價值鏈分析
• 市場生態系統
• 監管格局
• 創新矩陣
• 重大投資分析
• 關鍵成功因素
• 競爭程度

口服固體製劑市場（依產品類型）

• 市場概覽
• 藥片
  • 常規/即時釋放
  • 修復版本
  • 咀嚼錠
  • 發泡
• 膠囊
  • 硬明膠膠囊
  • 軟膠囊
• 粉末/顆粒
• 錠劑和軟糖
• 軟糖

口服固體製劑市場（依機制區分）

• 市場概覽
• 控釋
• 即時發布
• 延遲釋放

口服固體製劑市場（依最終用戶分類）

• 市場概覽
• 大型企業
• 中小企業
• 其他（Start-Ups和學名藥公司）

口服固體製劑市場規模（按地區）

• 市場概覽
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2024年）

主要企業簡介

• Pfizer Inc.（United States）
• Novartis AG（Switzerland）
• GlaxoSmithKline plc（United Kingdom）
• Sanofi SA（France）
• Merck & Co., Inc.（United States）

Oral Solid Dosage Pharmaceutical Formulation Market size was valued at USD 645.42 billion in 2023 and is poised to grow from USD 686.73 billion in 2024 to USD 1128.02 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The Global Oral Solid Dosage Pharmaceutical Formulation Market is poised for robust growth, driven by a rising demand for oral medications and advancements in drug formulation technologies. With an aging population that necessitates prolonged pharmaceutical treatment, the market is further supported by innovative drug delivery methods that enhance patient compliance and therapeutic effectiveness. Stricter regulations by authorities are compelling pharmaceutical companies to focus on quality and safety, leading to increased investments in research and development. Moreover, strategic collaborations between pharmaceutical firms and contract manufacturing organizations are expanding product portfolios and enhancing market dynamics. As a result, the oral solid dosage market is set for sustained evolution, aligning with the dynamic needs of the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Oral Solid Dosage Pharmaceutical Formulation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Oral Solid Dosage Pharmaceutical Formulation Market Segments Analysis

Global Oral Solid Dosage Pharmaceutical Formulation Market is segmented by Dosage Form, Drug Release Mechanism, Distribution Channel, Application, Manufacturing Route, Form, Dosage Strength, Route of Administration, Target Patient Population and region. Based on Dosage Form, the market is segmented into Tablets, Capsules, Powders and Granules, Lozenges and Pastilles and Gummies. Based on Drug Release Mechanism, the market is segmented into Immediate Release, Delayed Release and Controlled Release. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies and Hypermarkets/Supermarkets. Based on Application, the market is segmented into Cardiovascular, Anti-infectives, Central Nervous System, Pain Management, Anti-inflammatory and Others. Based on Manufacturing Route, the market is segmented into Direct Compression, Granulation, Extrusion-Spheronization, Coating and Film Coating. Based on Form, the market is segmented into Immediate Release, Sustained Release, Extended Release, Controlled Release and Enteric Coated. Based on Dosage Strength, the market is segmented into Low, Medium, High, Ultra-High and Specialty. Based on Route of Administration, the market is segmented into Oral, Sublingual, Buccal and Nasal. Based on Target Patient Population, the market is segmented into Adults, Geriatrics, Pediatrics, Neonates and Pregnant Women. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Oral Solid Dosage Pharmaceutical Formulation Market

Advancements in technology, such as 3-D printing, nanotechnology, and advanced drug delivery systems, are significantly improving the performance and efficacy of oral solid dosage pharmaceuticals. These innovations not only enhance patient adherence to medication regimens but also empower pharmaceutical companies to create novel formulations, thereby driving market growth. By harnessing these cutting-edge technologies, the industry is able to optimize drug effectiveness and tailor solutions to meet diverse patient needs, ultimately contributing to a more robust and dynamic Oral Solid Dosage Pharmaceutical Formulation market. As a result, these developments play a pivotal role in shaping the future of pharmaceutical manufacturing and patient care.

Restraints in the Oral Solid Dosage Pharmaceutical Formulation Market

The Oral Solid Dosage Pharmaceutical Formulation market faces significant constraints due to the intense scrutiny imposed by regulatory agencies globally, which aim to ensure the safety and effectiveness of drugs. The lengthy and complex approval processes associated with these regulations can lead to delays in product launches, increased development costs, and hinder market entry for new competitors. As companies strive to comply with these stringent requirements, navigating the regulatory landscape becomes a considerable challenge that can impact innovation and overall market growth in this sector. The need to meet such high standards remains a central obstacle for many organizations in the industry.

Market Trends of the Oral Solid Dosage Pharmaceutical Formulation Market

The Oral Solid Dosage Pharmaceutical Formulation market is experiencing a significant shift towards personalized medicine, driven by advancements in genetic profiling and biomarker identification. This trend enables pharmaceutical companies to create tailored formulations that cater to the unique needs of individual patients, significantly enhancing treatment efficacy and promoting adherence. As healthcare increasingly emphasizes patient-centric approaches, the demand for these customized oral solid dosage forms is projected to surge, cultivating niche markets within the industry. Companies focusing on precision formulations are likely to gain a competitive edge, fueling innovation and growth in this evolving landscape.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Oral Solid Dosage Pharmaceutical Market by Product Type

• Market Overview
• Tablets
  • Conventional/Immediate Release
  • Modified Release
  • Chewable Tablets
  • Effervescent Tablets
• Capsules
  • Hard Gelatin Capsules
  • Soft Gelatin Capsules
• Powders & Granules
• Lozenges & Pastilles
• Gummies

Oral Solid Dosage Pharmaceutical Market by Mechanism

• Market Overview
• Controlled-release
• Immediate-release
• Delayed-release

Oral Solid Dosage Pharmaceutical Market by End User

• Market Overview
• Large-size Companies
• Medium- & Small-size Companies
• Others (Startups & Generic Pharmaceutical Companies)

Oral Solid Dosage Pharmaceutical Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2024

Key Company Profiles

• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments